S. Koulla‐Shiro

发表

The in-vitro antimicrobial activity of some traditionally used medicinal plants against beta-lactam-resistant bacteria

M. Galleni, P. Ngassam, S. Koulla-Shiro, 2009 .

Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.

P. Ngassam, P. Ndumbe, T. Njiné, 2004, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Genotypic Diversity and Characterization of Quinolone Resistant Determinants from Enterobacteriaceae in Yaoundé, Cameroon

S. Koulla-Shiro, H. Gonsu, M. Assoumou, 2020, Open Journal of Medical Microbiology.

Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta.

C. Boye, S. Koulla-Shiro, S. Ben Redjeb, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The in-vitro antimicrobial activity of some medicinal plants against beta-lactam-resistant bacteria.

M. Galleni, P. Ngassam, B. Ngameni, 2009, Journal of infection in developing countries.

Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.

N. Ford, S. Jaffar, J. Klausner, 2019, The Lancet. Infectious diseases.

Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon.

P. Ngassam, P. Ndumbe, S. Koulla-Shiro, 2006, African health sciences.

Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in Douala, Cameroon: A Cross Sectional Study

H. Luma, S. Koulla-Shiro, E. Temfack, 2013, North American journal of medical sciences.

Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test

E. Delaporte, F. Dromer, T. Harrison, 2018, Front. Microbiol..

HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.

R. Bercion, C. Kuaban, S. Koulla‐Shiro, 1997, East African medical journal.

High rates of active hepatitis B and C co‐infections in HIV‐1 infected Cameroonian adults initiating antiretroviral therapy

E. Delaporte, A. Calmy, C. Laurent, 2010, HIV medicine.

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa

E. Delaporte, A. Calmy, S. Eymard-Duvernay, 2015, AIDS.

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

M. Peeters, F. Liégeois, E. Delaporte, 2004, The Lancet.

Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon

E. Delaporte, A. Calmy, N. Molinari, 2010, BMC public health.

Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon

Mamadou Camara, Jean-Paul Moatti, J. Moatti, 2010, AIDS.

Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine

E. Delaporte, A. Calmy, G. Peytavin, 2007, AIDS.

Evaluation of Four Tenofovir-Containing Regimens as First-Line Treatments in Cameroon and Senegal: The Anrs 12115 Dayana Trial

C. Charpentier, E. Delaporte, S. Eymard-Duvernay, 2014, Antiviral therapy.

Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study

G. Ashuntantang, S. Choukem, E. Temfack, 2012, The Pan African medical journal.

Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12‐116)

P. Ongolo-Zogo, J. Moatti, M. Carrieri, 2008, Tropical medicine & international health : TM & IH.

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon

M. Peeters, E. Delaporte, S. Eymard-Duvernay, 2013, Journal of the International AIDS Society.

Antiretroviral Drug Resistance and Routine Therapy, Cameroon

M. Peeters, E. Delaporte, C. Laurent, 2006, Emerging infectious diseases.

Dual therapy with a boosted protease inhibitor plus lamivudine is an effective maintenance strategy in patients on second-line antiretroviral therapy in Africa : the ANRS 12286/MOBIDIP trial

M. Peeters, E. Delaporte, S. Eymard-Duvernay, 2016 .

Mortality, AIDS-Morbidity, and Loss to Follow-up by Current CD4 Cell Count Among HIV-1–Infected Adults Receiving Antiretroviral Therapy in Africa and Asia: Data From the ANRS 12222 Collaboration

J. Etard, D. Zannou, S. Eholie, 2013, Journal of acquired immune deficiency syndromes.

Adherence to Antiretroviral Therapy Assessed by Drug Level Monitoring and Self-Report in Cameroon

E. Delaporte, A. Calmy, G. Peytavin, 2008, Journal of acquired immune deficiency syndromes.

Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.

E. Delaporte, J. Moatti, M. Carrieri, 2013, The Lancet. Infectious diseases.

Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City

S. Koulla-Shiro, H. Gonsu, Rolf Nyah Tuku Nzalie, 2016, International journal of microbiology.

Tuberculous meningitis: presentation, diagnosis and outcome in hiv-infected patients at the douala general hospital, cameroon: a cross sectional study

H. Luma, S. Koulla-Shiro, E. Temfack, 2013, AIDS Research and Therapy.

Characteristics of patients co-infected with HIV at the time of inpatient tuberculosis treatment initiation in Yaoundé, Cameroon: a tertiary care hospital-based cross-sectional study

J. Bigna, S. Billong, H. Abessolo, 2015, Archives of Public Health.

Factors Associated with Death during Tuberculosis Treatment of Patients Co-Infected with HIV at the Yaoundé Central Hospital, Cameroon: An 8-Year Hospital-Based Retrospective Cohort Study (2006–2013)

J. Bigna, S. Billong, R. Toby, 2014, PloS one.

Microbial etiology of acute community-acquired pneumonia in adult hospitalized patients in Yaounde-Cameroon.

L. Bélec, C. Kuaban, S. Koulla-Shiro, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon

E. Delaporte, M. Carrieri, B. Spire, 2015, Journal of acquired immune deficiency syndromes.

Effect of mobile phone reminders on follow-up medical care of children exposed to or infected with HIV in Cameroon (MORE CARE): a multicentre, single-blind, factorial, randomised controlled trial.

J. J. Noubiap, J. Bigna, Jean Joel R Bigna, 2014, The Lancet. Infectious diseases.

Susceptibility to Transmitting HIV in Patients Initiating Antiretroviral Therapy in Rural District Hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial)

M. Peeters, E. Delaporte, J. Moatti, 2013, PloS one.

Implementing operational research to scale-up access to antiretroviral therapy for HIV infection: lessons learned from the Cameroonian experience

J. Moatti, B. Spire, S. Boyer, 2011, Current opinion in HIV and AIDS.

Early Mortality during Initial Treatment of Tuberculosis in Patients Co-Infected with HIV at the Yaoundé Central Hospital, Cameroon: An 8-Year Retrospective Cohort Study (2006-2013)

J. Bigna, S. Billong, C. S. Plottel, 2015, PloS one.

Human Immunodeficiency Virus Infection and Associated Factors among Specific Population Subgroups in Cameroon

S. Koulla-Shiro, A. Bella, J. Mosoko, 2009, AIDS and Behavior.

Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.

E. Delaporte, M. Carrieri, B. Spire, 2011, The Lancet. Infectious diseases.

Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count

J. Bigna, C. S. Plottel, S. Koulla‐Shiro, 2016, Infectious Diseases of Poverty.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.

M. Peeters, E. Delaporte, S. Eymard-Duvernay, 2017, The lancet. HIV.

TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study

E. Delaporte, S. Eymard-Duvernay, A. Diouf, 2017, PloS one.

Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116)

P. Ongolo-Zogo, J. Moatti, M. Carrieri, 2010, AIDS care.

Molecular Diversity of Staphylococcus aureus from the Nares of Hospital Personnel, HIV-Positive and Diabetes Mellitus Patients in Yaounde Cameroon

C. Fokunang, M. Ehlers, M. Kock, 2021, Advances in Microbiology.

Phenotypic detection of extended spectrum beta-lactamase and carbapenemases produced by Klebsiella spp. isolated from three referrals hospitals in Yaounde, Cameroon.

E. Lyonga, M. Toukam, Anicette Chafa Betbeui, 2015 .

Resistance pattern of enterobacteriaceae isolates from urinary tract infections to selected quinolones in Yaoundé

H. Gonsu, M. Assoumou, C. Nkenfou, 2015, The Pan African medical journal.

Individual and Structural Factors Associated With HIV Status Disclosure to Main Partner in Cameroon: ANRS 12-116 EVAL Survey, 2006–2007

M. Carrieri, B. Spire, M. Suzan-Monti, 2011, Journal of acquired immune deficiency syndromes.

APOL1 Renal Risk Variants and Kidney Function in HIV-1–Infected People From Sub-Saharan Africa

S. Eymard-Duvernay, N. Meda, C. Kouanfack, 2021, Kidney international reports.

Adult response to initial treatment with ampicillin in community acquired pneumonia in Yaoundé, Cameroon.

R. Auckenthaler, L. Bélec, C. Kuaban, 1993, The Central African journal of medicine.

Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.

E. Delaporte, D. Costagliola, B. Chaix, 2013, The Journal of antimicrobial chemotherapy.

Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011–2018

S. Madhi, B. Gessner, E. Begier, 2021, PloS one.

Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction.

O. Nyholm, S. Koulla-Shiro, A. Palmu, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

J. Bigna, S. Koulla-Shiro, P. Sime, 2015, AIDS Research and Therapy.

New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon

E. Delaporte, D. Costagliola, A. Minga, 2015, Bulletin of the World Health Organization.

Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.

E. Delaporte, A. Calmy, C. Laurent, 2008, AIDS research and human retroviruses.

Ending AIDS as a Public Health Threat by 2030: Scientific Developments from the 2016 Interest Conference in Yaoundé, Cameroon

C. Boucher, G. Ferrari, E. Katabira, 2017, Antiviral therapy.

The prevalence of otitis media in 2-3 year old Cameroonian children estimated by tympanometry.

H. Huhtala, A. Palmu, H. Nohynek, 2018, International journal of pediatric otorhinolaryngology.

Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.

M. Peeters, E. Delaporte, C. Laurent, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Task Shifting HIV Care in Rural District Hospitals in Cameroon: Evidence of Comparable Antiretroviral Treatment-Related Outcomes Between Nurses and Physicians in the Stratall ANRS/ESTHER Trial

E. Delaporte, M. Carrieri, B. Spire, 2013, Journal of acquired immune deficiency syndromes.

Short Communication: Nucleoside Reverse Transcriptase Inhibitors with Reduced Predicted Activity Do Not Impair Second-Line Therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir.

M. Peeters, E. Delaporte, S. Eymard-Duvernay, 2018, AIDS research and human retroviruses.

Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial).

C. Delaugerre, S. Eymard-Duvernay, A. Amara, 2021, The Journal of antimicrobial chemotherapy.

Toxoplasma encephalitis in HIV/AIDS patients admitted to the Douala general hospital between 2004 and 2009: a cross sectional study

H. Luma, E. Temfack, M. Doualla, 2013, BMC Research Notes.

Lower lung field tuberculosis in Yaounde, Cameroon.

C. Kuaban, J. G. Fotsin, P. Hagbe, 1996, The Central African journal of medicine.

Toxoplasma encephalitis in HIV/AIDS patients admitted to the Douala general hospital between 2004 and 2009: a cross sectional study

H. Luma, E. Temfack, M. Doualla, 2013, BMC Research Notes.

Acute community-acquired bacterial pneumonia in Human Immunodeficiency Virus (HIV) infected and non-HIV-infected adult patients in Cameroon: aetiology and outcome.

L. Bélec, C. Kuaban, S. Koulla‐Shiro, 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Factors associated with non-adherence to scheduled medical follow-up appointments among Cameroonian children requiring HIV care: a case-control analysis of the usual-care group in the MORE CARE trial

J. Bigna, C. Kouanfack, C. S. Plottel, 2014, Infectious Diseases of Poverty.

Performance of HIV care decentralization from the patient's perspective: health-related quality of life and perceived quality of services in Cameroon.

J. Moatti, M. Carrieri, C. Protopopescu, 2012, Health policy and planning.

Higher risk of unsafe sex and impaired quality of life among patients not receiving antiretroviral therapy in Cameroon: results from the EVAL survey (ANRS 12–116)

M. Carrieri, B. Spire, F. Marcellin, 2010, AIDS.

Evolution of Renal Function in African Patients Initiating Second-Line Antiretroviral Treatment: Findings from the ANRS 12169 2LADY Trial

E. Delaporte, S. Eymard-Duvernay, A. Diouf, 2016, Antiviral therapy.

Prevalence of unsafe sex with one's steady partner either HIV-negative or of unknown HIV status and associated determinants in Cameroon (EVAL ANRS12-116 survey)

M. Carrieri, C. Protopopescu, B. Spire, 2009, Sexually Transmitted Infections.

Cross-sectional assessment of three commonly used measures of adherence to combination antiviral therapy in a resource limited setting

H. Luma, E. Asongalem, E. Temfack, 2017, International journal of STD & AIDS.